Key regions: United Kingdom, Canada, Japan, Europe, China
The Dermatological Drugs market in Southern Africa has been steadily growing in recent years.
Customer preferences: Southern African customers have shown a preference for dermatological drugs that are effective in treating skin conditions such as eczema, acne, and psoriasis. They also prefer products that are affordable and easily accessible.
Trends in the market: One notable trend in the Southern African dermatological drugs market is the increasing demand for natural and organic products. Consumers are becoming more conscious of the ingredients in their skincare products and are seeking out products that are free from harmful chemicals. Another trend is the rise of e-commerce platforms, which have made it easier for consumers to access a wider range of products from the comfort of their homes.
Local special circumstances: One of the unique challenges facing the Southern African dermatological drugs market is the high prevalence of skin conditions such as eczema and psoriasis. This has led to a high demand for effective treatments. Additionally, the region's hot and dry climate can exacerbate skin conditions, making it even more important for consumers to have access to effective treatments.
Underlying macroeconomic factors: The Southern African dermatological drugs market is influenced by a number of macroeconomic factors, including the region's economic growth, population growth, and healthcare spending. As the region's economy continues to grow, more consumers will have the disposable income to spend on dermatological drugs. Additionally, as the population grows, there will be an increasing demand for healthcare services, including dermatological treatments. Finally, as healthcare spending increases, more resources will be allocated towards the development and distribution of dermatological drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
